inVentiv Health selected ClinPhone EDC for its trials. Under the arrangement, inVentiv will transfer the technology in-house. Mike Hlinak, president and CEO of inVentiv Clinical Solutions said: “This agreement with ClinPhone allows us to further broaden our service offering by adding our own EDC system which will no doubt better service the increasing needs of our clients for speed and accuracy of clinical trial data. The addition of our own EDC platform also solidifies our position in the market as the clear leader in providing flexible, cost effective clinical outsourcing solutions.”

Clinipace, a clinical research software company, and Clinlogix, a global clinical trial management organization, announced today the success of their new partnership and the recent wins of two oncology trial projects worth more than $1 million. Clinipace’s empowered partner program (EPP) is an innovative program designed for small and medium-sized CROs, like Clinlogix, to combine their services with Clinipace’s eClinical suite and offer a truly comprehensive offering. By providing a more comprehensive service offering to Clinlogix’s clients with Clinipace’s technology, Clinlogix can compete more effectively with larger, full-service CROs, while still maintaining its own high level of specialized client service.

Bob Lyons, co-founder and chief technology officer of electronic data capture firm Nextrials, was selected as a winner in the annual “Top 25 Chief Technology Officers for 2007” competition by InfoWorld magazine. “This year’s CTO 25 award winners are true visionaries who believe that leading edge technology equals leading edge business,” said Steve Fox, InfoWorld editor-in-chief. Lyons is indeed a visionary. Here’s some recent news at the company’s website.

Two years ago, the International Committee of Medical Journal Editors (ICMJE) threw down the gauntlet before the pharmaceutical industry. The ICMJE announced that its member journals (including the New England Journal of Medicine [NEJM], Lancet, and Journal of the American Medical Association) would review for publication only studies that had deposited information about their trial design into an approved clinical trial registry before enrolling patients. This week the ICMJE, in an editorial in the NEJM, looked back with satisfaction at the “overwhelming” response to its watershed 2005 initiative. “The research community has embraced trial registration,” states the NEJM editorial, citing the more than tripling of the number of trials in ClinicalTrials.gov. There were 13,154 trials listed before the ICMJE announced its policy; the number is 40,000 now. Looking ahead, the ICMJE recognizes the growing call for registration not only of trial methods, but also of trial results. A federal requirement to post results could directly threaten the journal editors’ control of some trial data.

Enzo Biochem announced recently that its wholly owned subsidiary, Enzo Life Sciences has completed the acquisition of Axxora Life Sciences, a privately owned global manufacturer and marketer of life science research products. Enzo Biochem is engaged in the research, development and manufacture of innovative health care products based on molecular biology and genetic engineering techniques, and in providing diagnostic services to the medical community. Enzo’s Life Sciences division develops, produces and markets proprietary labeling and detection products for gene sequencing and genetic analysis.

Aptuit, a company focused on streamlining and supporting the drug development process, has secured its first integrated drug delivery contract from Danube Pharmaceuticals. Aptuit will provide the company with a full range of drug development services and employ five of its global facilities to develop and manufacture Danube’s investigational compound in support of upcoming Phase II clinical trials. The project will include a wide range of Aptuit’s services, including API process development, cGMP API delivery, clinical manufacture, analytical services, clinical packaging and labeling, and qualified person release. With its full suite of global services, as well as horizontal project management, Aptuit can execute complex projects at all stages of development and minimize intelligence transfer obstacles across technology and processes. The Danube project will utilize Aptuit’s specialized teams and facilities in Harrisonville and Kansas City, Missouri; Bathgate and Riccarton, Scotland; and Deeside, Wales. The work will be coordinated by a central Aptuit project manager responsible for full integration of services.

Two Chinese contract research organizations are merging, an apparent first in the industry there. Sundia MediTech and Shanghai United PharmaTech announced that they are joining forces. Both will be controlled by a holding company in the British Virgin Islands, Sundia Investment Group.

Have a news release? Send it to .(JavaScript must be enabled to view this email address).